RSS

Avastin

The controversy surrounding Avastin and Lucentis has reared its head again as it has been revealed that health chiefs may face a legal fight if they go ahead with plans to offer the cheaper drug (Avastin) to patients with wet AMD on the NHS more

News

The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) as a biosimilar to the cancer treatment Avastin (bevacizumab). This represents the first biosimilar approved by the regulatory body for cancer treatment. more

News

FDA has approved Avastin in combination with paclitaxel and cisplatin or paclitaxel and topotecan for the treatment of metastatic carcinoma of the cervix. more